Science
COVID-19: First data shows BioNTech-Pfizer '100% effective' in young teenagers
Initial data (that has yet to be peer reviewed) suggests the BioNTech-Pfizer vaccine may work even better for young teens than it does for adults — due to an even stronger antibody reaction. The announcement came a day after Germany halted the use of AstraZeneca for anyone under 60.
WWW links
- Date 31.03.2021
- Duration 08:27 mins.
- Author Gabriel Borrud, Conor Dillon
- All audios Science unscripted
- Related Subjects Germany, Israel, Coronavirus, Coronavirus vaccine, Fatah
- Keywords COVID-19, coronavirus, BioNTech-Pfizer, teens, teenagers, effective, work, 100, children, side effects, Israel, AstraZeneca, Germany, stopped, using, under 60, cerebral venous sinus thrombosis
- Download Save MP3 file
- Embed Embed audio
- Print Print this page
- Permalink https://p.dw.com/p/3rRGk
